Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Semaphorin-6B is a member of the semaphorin family, specifically the class 6 transmembrane semaphorins, and functions primarily as a cell-surface repellent influencing axon guidance, cell migration, and neural circuit development. It contains characteristic sema and PSI (plexin-semaphorin-integrin) domains, and is highly expressed in heart and brain tissues but also found throughout the body at lower levels. Semaphorin-6B has a well-documented role in neurodevelopment, especially in the guidance of mossy fibers in the hippocampus, and interacts with plexin family receptors, particularly Plexin A2 and A4. Genetic variants, including truncating and missense mutations, have been directly linked to progressive myoclonic epilepsy and may be relevant in other neurodevelopmental and oncologic diseases
Not fully established for drugs; retinoic acid modulates SEMA6B via RXR/PPAR-mediated transcriptional repression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Semaphorin-6B (SEMA6B).